Pharmaceuticals

Pharma major Lupin Limited announced on Saturday that its U.S subsidiary, Lupin Pharmaceuticals, Inc. (LPI) has received tentative approval for the company’s Abbreviated New Drug Application (ANDA) for Eszopiclone tablets, 1 mg, 2 mg and 3 mg from the U.S. Food and Drug Administration (USFDA).

India is emerging as an exciting destination for global pharmaceutical firms

Ranbaxy Laboratories will launch parent Daiichi Sankyo's antihypertensive drug Olmesartan Medoxomil in six African countries the companies said on Monday.

Ranbaxy will launch the drug in Kenya Mozambique

City-based Orchid Chemicals & Pharmaceuticals has received the final approval from the US Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for Zaleplon Capsules.

Orchid Chemicals & Pharmaceuticals today said it has received the US nod.

ICICI expects the infrastructure, pharmaceuticals, education and IT sector